Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors

Molecular and Cellular Endocrinology

Volumn 291, Issue 1-2, 2008, Pages 57-62

  Ciampi, Raffaele ^a   Vivaldi, Agnese ^a   Romei, Cristina ^a   Del Guerra, Alberto ^a   Salvadori, Piero ^b   Cosci, Barbara ^a   Pinchera, Aldo ^a   Elisei, Rossella ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

Author keywords

18FDG; Cell lines; GLUT; Thyroid carcinoma

Indexed keywords

DEOXYGLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 10; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 6; GLUCOSE TRANSPORTER 8; MESSENGER RNA;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER TISSUE; CELL LINE; CONTROLLED STUDY; FOLLICULAR CARCINOMA; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLARY CARCINOMA; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; WESTERN BLOTTING;

CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; DEOXYGLUCOSE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 48349138947     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.05.003     Document Type: Article

References (30)

1. Boado R.J., Black K.L., and Pardridge W.M. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res. Mol. Brain Res. 27 (1994) 51-57
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Burant C.F., and Bell G.I. Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins. Biochemistry 31 (1992) 10414-10420
4. Conti P.S., Durski J.M., Bacqai F., Grafton S.T., and Singer P.A. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9 (1999) 797-804
5. Elisei R., Vivaldi A., Agate L., Ciampi R., Molinaro E., Piampiani P., Romei C., Faviana P., Basolo F., Miccoli P., Capodanno A., Collecchi P., Pacini F., and Pinchera A. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J. Clin. Endocrinol. Metab. 90 (2005) 2403-2411
6. Frilling A., Tecklenborg K., Gorges R., Weber F., Clausen M., and Broelsch E.C. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann. Surg. 234 (2001) 804-811
7. Gould G.W., Thomas H.M., Jess T.J., and Bell G.I. Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 30 (1991) 5139-5145
8. Grunwald F., Kalicke T., Feine U., Lietzenmayer R., Scheidhauer K., Dietlein M., Schober O., Lerch H., Brandt-Mainz K., Burchert W., Hiltermann G., Cremerius U., and Biersack H.J. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur. J. Nucl. Med. 26 (1999) 1547-1552
9. Haber R.S., Weiser K.R., Pritsker A., Reder I., and Burstein D.E. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7 (1997) 363-367
10. Hatanaka M. Transport of sugars in tumor cell membranes. Biochim. Biophys. Acta 355 (1974) 77-104
11. Higashi T., Tamaki N., Torizuka T., Nakamoto Y., Sakahara H., Kimura T., Honda T., Inokuma T., Katsushima S., Ohshio G., Imamura M., and Konishi J. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J. Nucl. Med. 39 (1998) 1727-1735
12. Isselbacher K.J. Increased uptake of amino acids and 2-deoxy-d-glucose by virus-transformed cells in culture. Proc. Natl. Acad. Sci. U.S.A. 69 (1972) 585-589
13. Isselbacher K.J. Sugar and amino acid transport by cells in culture: differences between normal and malignant cells. N. Engl. J. Med. 286 (1972) 929-933
14. Joost H.G., Bell G.I., Best J.D., Birnbaum M.J., Charron M.J., Chen Y.T., Doege H., James D.E., Lodish H.F., Moley K.H., Moley J.F., Mueckler M., Rogers S., Schurmann A., Seino S., and Thorens B. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E974-E976
15. Joost H.G., and Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr. Biol. 18 (2001) 247-256
16. Khan N., Oriuchi N., Higuchi T., and Endo K. Review of fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas. Cancer Control 12 (2005) 254-260
17. Kresnik E., Gallowitsch H.J., Mikosch P., Stettner H., Igerc I., Gomez I., Kumnig G., and Lind P. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133 (2003) 294-299
18. Macheda M.L., Rogers S., and Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol. 202 (2005) 654-662
19. Matsuzu K., Segade F., Matsuzu U., Carter A., Bowden D.W., and Perrier N.D. Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid 14 (2004) 806-812
20. Matsuzu K., Segade F., Wong M., Clark O.H., Perrier N.D., and Bowden D.W. Glucose transporters in the thyroid. Thyroid 15 (2005) 545-550
21. Plotkin M., Hautzel H., Krause B.J., Schmidt D., Larisch R., Mottaghy F.M., Boemer A.R., Herzog H., Vosberg H., and Muller-Gartner H.W. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer. Thyroid 12 (2002) 155-161
22. Rogers S., Docherty S.E., Slavin J.L., Henderson M.A., and Best J.D. Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer Lett. 193 (2003) 225-233
23. Samih N., Hovsepian S., Notel F., Prorok M., Zattara-Cannoni H., Mathieu S., Lombardo D., Fayet G., and El-Battari A. The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells. Biochim. Biophys. Acta 1621 (2003) 92-101
24. Schonberger J., Ruschoff J., Grimm D., Marienhagen J., Rummele P., Meyringer R., Kossmehl P., Hofstaedter F., and Eilles C. Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid 12 (2002) 747-754
25. Scott A.M. Current status of positron emission tomography in oncology. Intern. Med. J. 31 (2001) 27-36
26. Stokkel M.P., Duchateau C.S., and Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q. J. Nucl. Med. Mol. Imaging 50 (2006) 78-87
27. Strauss L.G., and Conti P.S. The applications of PET in clinical oncology. J. Nucl. Med. 32 (1991) 623-648 discussion 649-650
28. Stuart C.A., Yin D., Howell M.E., Dykes R.J., Laffan J.J., and Ferrando A.A. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E1067-E1073
29. van Staveren W.C., Solis D.W., Delys L., Duprez L., Andry G., Franc B., Thomas G., Libert F., Dumont J.E., Detours V., and Maenhaut C. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res. 67 (2007) 8113-8120
30. Yamamoto T., Seino Y., Fukumoto H., Koh G., Yano H., Inagaki N., Yamada Y., Inoue K., Manabe T., and Imura H. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170 (1990) 223-230